These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 7106459

  • 1. [Piretanide in the therapy of water-sodium retention in hepatic cirrhosis].
    Scarpioni L, Crippa G, Zanazzi MA.
    G Clin Med; 1982 Jan; 63(1):57-76. PubMed ID: 7106459
    [No Abstract] [Full Text] [Related]

  • 2. [Water and sodium metabolism in non-compensated hepatic cirrhosis: therapeutic indications according to the Arroyo classification].
    Cavatorta F, Queirolo C, Brignole M, Zangani F.
    Clin Ter; 1980 Jan 31; 92(2):143-53. PubMed ID: 7389274
    [No Abstract] [Full Text] [Related]

  • 3. [Disorders of water-electrolyte balance in chronic hepatitis and liver cirrhosis].
    Dederer IuM, Rozhkova TA.
    Ter Arkh; 1975 Jan 31; 47(2):72-8. PubMed ID: 1145463
    [No Abstract] [Full Text] [Related]

  • 4. [Water-electrolyte disorders and their importance in the etiopathogenesis and physiopathology of edemas].
    Del Nero Júnior E, Lima EV.
    Arq Bras Cardiol; 1981 Jan 31; 36(1):59-71. PubMed ID: 7023432
    [No Abstract] [Full Text] [Related]

  • 5. [Various indicators of water-electrolyte metabolism in ulcer and cancer of the stomach].
    Komakhidze ME, Akhmeteli TI, Papava RI.
    Vestn Khir Im I I Grek; 1977 Mar 31; 118(3):126-7. PubMed ID: 878179
    [Abstract] [Full Text] [Related]

  • 6. [Effect of diuretic treatment on body composition in liver cirrhosis: radioisotope dilution study of the effect of amiloride (MK-870)].
    Quoidbach A, Busset R, Jenny M.
    Praxis; 1969 Sep 23; 58(38):1197-201. PubMed ID: 4910991
    [No Abstract] [Full Text] [Related]

  • 7. [Changes in renal function and the intracellular environment in cirrhotic patients].
    Tiberio López G, Tanco S, Orradre B, Berrade MF, Anderiz López M.
    Rev Esp Enferm Apar Dig; 1985 Apr 23; 67(4):367-78. PubMed ID: 2988084
    [No Abstract] [Full Text] [Related]

  • 8. [Electrolyte metabolism anomalies in liver cirrhosis].
    Okumura M, Katsuki S.
    Saishin Igaku; 1968 Dec 10; 23(12):2527-33. PubMed ID: 4889816
    [No Abstract] [Full Text] [Related]

  • 9. [Renal and extra-renal mechanisms of sodium and water retention in cirrhosis with ascites].
    Peña JC.
    Rev Invest Clin; 1995 Dec 10; 47(1):63-79. PubMed ID: 7777718
    [Abstract] [Full Text] [Related]

  • 10. Impaired free water excretion in child C cirrhosis and ascites: relations to distal tubular function and the vasopressin system.
    Krag A, Møller S, Pedersen EB, Henriksen JH, Holstein-Rathlou NH, Bendtsen F.
    Liver Int; 2010 Oct 10; 30(9):1364-70. PubMed ID: 20731774
    [Abstract] [Full Text] [Related]

  • 11. Disordered sodium metabolism: sodium retention states.
    Cadnapaphornchai P.
    Crit Care Clin; 1987 Oct 10; 3(4):779-95. PubMed ID: 3332224
    [Abstract] [Full Text] [Related]

  • 12. Pathology of structured water and associated cations in cells (ther tissue damage syndrome) and its medical treatment.
    Cope FW.
    Physiol Chem Phys; 1977 Oct 10; 9(6):547-53. PubMed ID: 614594
    [Abstract] [Full Text] [Related]

  • 13. [Physiopathology and treatment of ascites in the cirrhotic patient].
    Rodés J, Arroyo V.
    Rev Med Brux; 1987 Apr 10; 8(4):204-8. PubMed ID: 3589268
    [No Abstract] [Full Text] [Related]

  • 14. [Therapeutic possibilities and risks in hepatic cirrhosis with water-electrolyte metabolism disorders].
    Schwartz M, Fodor O.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975 Apr 10; 27(3):219-25. PubMed ID: 770
    [No Abstract] [Full Text] [Related]

  • 15. [Balance and limits of the distribution of potassium, osmotically active sodium and water. Clinical studies of normal and pathologic variations].
    Leppla W.
    Ann Univ Sarav Med; 1966 Apr 10; 13(4):183-261. PubMed ID: 5991413
    [No Abstract] [Full Text] [Related]

  • 16. Use of the oral diuretics, aminometradine and aminoisometradine, in the sodium and water retention of hepatic cirrhosis.
    WATSON DD, BALFOUR DC.
    Gastroenterology; 1957 Aug 10; 33(2):202-8. PubMed ID: 13462067
    [No Abstract] [Full Text] [Related]

  • 17. Concurrent use of phenytoin and furosemide: problems in a patient with congestive cardiac failure, chronic renal failure, liver cirrhosis and fluid overload.
    Bissoli F, Gini G, Bosio M, Ceriani R.
    Recenti Prog Med; 1996 May 10; 87(5):227-8. PubMed ID: 8767760
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of the hepatorenal syndrome with metaraminol.
    Sugerman HJ, Berkowitz HD, Davidson DT, Miller LD.
    Surg Forum; 1970 May 10; 21():359-61. PubMed ID: 5514762
    [No Abstract] [Full Text] [Related]

  • 19. [Autogenous intravenous infusion of ascitic fluid in patients with liver cirrhosis].
    Selmi W.
    Minerva Med; 1973 May 10; 64(53):2764-74. PubMed ID: 4726749
    [No Abstract] [Full Text] [Related]

  • 20. Pathogenesis of water and sodium retention in cirrhosis.
    Martin PY, Schrier RW.
    Kidney Int Suppl; 1997 Jun 10; 59():S43-9. PubMed ID: 9185104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.